These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 282006)

  • 41. Flat revertant inducers, styryl diphenylamine derivatives, inhibit growth and metastasis of murine tumor cells in vivo.
    Ohizumi I; Tanemura M; Tsunenari T; Sato K; Kozono T; Kaiho S
    Anticancer Res; 1997; 17(1A):393-400. PubMed ID: 9066683
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Antitumor effect of human recombinant interferon-alpha A/D in mice(I): Comparison between systemic and lesional treatment of meth-A sarcoma in BALB/c mice].
    Nanjo M; Yoshie O; Aso H; Ebina T; Ishida N
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):505-9. PubMed ID: 4004283
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preclinical evaluation of bryostatin as an anticancer agent against several murine tumor cell lines: in vitro versus in vivo activity.
    Hornung RL; Pearson JW; Beckwith M; Longo DL
    Cancer Res; 1992 Jan; 52(1):101-7. PubMed ID: 1727368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of hematopoietic suppressor molecules on the in vitro proliferation of purified murine granulocyte-macrophage progenitor cells.
    Williams DE; Cooper S; Broxmeyer HE
    Cancer Res; 1988 Mar; 48(6):1548-50. PubMed ID: 2449953
    [TBL] [Abstract][Full Text] [Related]  

  • 45. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
    Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
    Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhancement of interferon antitumor action by sodium butyrate.
    Bourgeade MF; Cerutti I; Chany C
    Cancer Res; 1979 Nov; 39(11):4720-3. PubMed ID: 498098
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characteristics of osteosarcoma cells in culture.
    Amitani K; Nakata Y
    Clin Orthop Relat Res; 1977; (122):315-24. PubMed ID: 264806
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Studies on the tissue culture of murine sarcoma (Dunn sarcoma)--a fix cell line established in vitro (DSK) and its cytokinetic findings (author's transl)].
    Oosaki Y
    Nihon Seikeigeka Gakkai Zasshi; 1982 Jan; 56(1):37-49. PubMed ID: 6950991
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative antitumor activity of actinomycin analogs in mice bearing Ridgway osteogenic sarcoma or P388 leukemia.
    Rose WC; Trader MW; Laster WR; Schabel FM
    Cancer Treat Rep; 1978 May; 62(5):779-89. PubMed ID: 77730
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of the growth of murine tumour cells in vitro by serum from non-immune syngeneic and allogeneic mice.
    Ablett G; Bishop C; Sheridan JW; Donald KJ
    Br J Exp Pathol; 1978 Oct; 59(5):522-9. PubMed ID: 102333
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antitumor effect of human recombinant interferon-gamma and -beta against human osteosarcoma transplanted into nude mice.
    Gomi K; Oka T; Morimoto M
    J Pharmacobiodyn; 1986 Nov; 9(11):879-88. PubMed ID: 3104572
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of poly I:C/poly-L-lysine (poly ICL) on the development of murine osteogenic sarcoma.
    Davies ME; Field AK
    J Interferon Res; 1983; 3(1):89-95. PubMed ID: 6573430
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sensitivity of human ovarian carcinoma cells to interferon and other antitumor agents as assessed by an in vitro semi-solid agar technique.
    Epstein LB; Shen JT; Abele JS; Reese CC
    Ann N Y Acad Sci; 1980; 350():228-44. PubMed ID: 6165278
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies on the cytotoxicity of penicillamine in a rat osteogenic sarcoma.
    Cosolo W; Christophidis N; Drummer OH; Findlay DM
    Clin Exp Pharmacol Physiol; 1986 Oct; 13(10):737-43. PubMed ID: 3467882
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Further studies on anti-tumor activity of adenovirus fibre protein on murine sarcoma tumours.
    Khoobyarian N
    J Gen Virol; 1981 Feb; 52(Pt 2):377-80. PubMed ID: 6169787
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-tumor effects of water-soluble propolis on a mouse sarcoma cell line in vivo and in vitro.
    Inoue K; Saito M; Kanai T; Kawata T; Shigematsu N; Uno T; Isobe K; Liu CH; Ito H
    Am J Chin Med; 2008; 36(3):625-34. PubMed ID: 18543394
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sustained release of adriamycin from implanted hydroxyapatite blocks for the treatment of experimental osteogenic sarcoma in mice.
    Itokazu M; Kumazawa S; Wada E; Wenyi Y
    Cancer Lett; 1996 Oct; 107(1):11-8. PubMed ID: 8913261
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antitumor activity of polysaccharides. II. Growth-inhibitory activity of mannan fractions isolated from several species of yeasts against sarcoma-180 solid tumor.
    Suzuki S; Hatsukaiwa H; Sunayama H; Uchiyama M; Fukuoka F
    Gan; 1969 Feb; 60(1):65-9. PubMed ID: 5781977
    [No Abstract]   [Full Text] [Related]  

  • 59. [Modifying effects of interferon (IFN) on the growth of irradiated sarcoma 180 cells in vitro].
    Miyoshi T; Saito M; Arimizu N; Akiyama S
    Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Jan; 44(1):88-92. PubMed ID: 6204272
    [No Abstract]   [Full Text] [Related]  

  • 60. Interferon therapy for neoplastic diseases in man in vitro and in vivo studies.
    Einhorn S; Strander H
    Adv Exp Med Biol; 1978; 110():159-74. PubMed ID: 727040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.